KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 143 filers reported holding KRYSTAL BIOTECH INC in Q4 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $144,536 | +5.2% | 1,246 | +6.5% | 0.01% | +14.3% |
| Q2 2023 | $137,358 | +52.2% | 1,170 | +3.8% | 0.01% | +40.0% |
| Q1 2023 | $90,228 | -11.2% | 1,127 | -12.2% | 0.01% | 0.0% |
| Q4 2022 | $101,639 | +13.7% | 1,283 | 0.0% | 0.01% | +25.0% |
| Q3 2022 | $89,425 | +6.2% | 1,283 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $84,242 | -1.3% | 1,283 | 0.0% | 0.00% | +33.3% |
| Q1 2022 | $85,371 | -74.5% | 1,283 | -73.2% | 0.00% | -40.0% |
| Q4 2021 | $334,781 | +34.0% | 4,786 | 0.0% | 0.01% | +25.0% |
| Q3 2021 | $249,877 | -21.7% | 4,786 | +1.9% | 0.00% | 0.0% |
| Q2 2021 | $319,260 | -5.5% | 4,695 | +7.1% | 0.00% | -20.0% |
| Q1 2021 | $337,743 | +21.8% | 4,384 | -5.1% | 0.01% | +25.0% |
| Q4 2020 | $277,320 | +39.4% | 4,622 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $198,977 | +3.9% | 4,622 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $191,443 | +35.7% | 4,622 | +41.7% | 0.00% | 0.0% |
| Q1 2020 | $141,049 | -21.9% | 3,262 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $180,650 | +59.5% | 3,262 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $113,273 | +295.6% | 3,262 | +358.8% | 0.00% | – |
| Q2 2019 | $28,631 | – | 711 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
| Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
| S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
| Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
| Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
| Artal Group S.A. | 412,082 | $32,991 | 1.96% |
| First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
| Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
| Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |